PTHLH and osteoporosis: PTHrP is well-recognized to play a role in bone formation [1,2,3] along with abaloparatide, an analog of PTHrP(1-34), approved in 2017 for the treatment of osteoporosis in post-menopausal women at high risk for bone fractures [4,5,6,7].